Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$150M |
| 2 |
ExxonMobil
XOM
|
+$121M |
| 3 |
Visa
V
|
+$94.9M |
| 4 |
Columbia Banking Systems
COLB
|
+$94.4M |
| 5 |
GE HealthCare
GEHC
|
+$89.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$320M |
| 2 |
JPMorgan Chase
JPM
|
+$209M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$96.7M |
| 4 |
GE Aerospace
GE
|
+$89M |
| 5 |
ConocoPhillips
COP
|
+$88.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.82% |
| 2 | Financials | 16.13% |
| 3 | Industrials | 13.26% |
| 4 | Healthcare | 11.06% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Corbus Pharmaceuticals
CRBP
$168M
| $99.5K | ﹤0.01% |
+13,681
| New | +$59.9K |
|
|
BCEL
3302
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $98.9K | ﹤0.01% |
86,797
| – | – |
|
3303
Beyond Air
XAIR
$3.91M
| $98.6K | ﹤0.01% |
37
+3
| +9% | +$7.67K |
|
|
ZEPP
3304
Zepp Health
ZEPP
$64.8M
| $97.8K | ﹤0.01% |
18,666
-8,188
| -30% | -$58K |
|
3305
Blink Charging
BLNK
$70.4M
| $97.4K | ﹤0.01% |
+11,255
| New | +$119K |
|
|
RDFN
3306
DELISTED
Redfin
RDFN
| $97.1K | ﹤0.01% |
10,715
-66,557
| -86% | -$496K |
|
|
PVLA
3307
Palvella Therapeutics
PVLA
$2.15B
| $96.8K | ﹤0.01% |
1,240
-93
| -7% | -$10.8K |
|
|
IRD
3308
Opus Genetics
IRD
$317M
| $96K | ﹤0.01% |
25,592
| – | – |
|
3309
CPS Technologies
CPSH
$77.3M
| $95.4K | ﹤0.01% |
33,583
| – | – |
|
|
AFMD
3310
DELISTED
Affimed
AFMD
| $94.9K | ﹤0.01% |
12,723
-11,078
| -47% | -$111K |
|
3311
Smartbird Inc
BIRD
$20.3M
| $94.7K | ﹤0.01% |
3,946
+254
| +7% | +$11.7K |
|
3312
VirTra
VTSI
$35.7M
| $92.2K | ﹤0.01% |
22,874
+5,467
| +31% | +$24.6K |
|
3313
Workhorse Group
WKHS
$34.5M
| $91.9K | ﹤0.01% |
23
-15
| -39% | -$82.8K |
|
|
TULP
3314
Bloomia Holdings
TULP
$15.6M
| $91.7K | ﹤0.01% |
12,704
| – | – |
|
3315
Cineverse
CNVS
$56M
| $91.4K | ﹤0.01% |
10,882
-2,046
| -16% | -$20.7K |
|
3316
Anixa Biosciences
ANIX
$121M
| $91.1K | ﹤0.01% |
21,177
| – | – |
|
3317
Gain Therapeutics
GANX
$75.1M
| $89.7K | ﹤0.01% |
18,607
+6,661
| +56% | +$27.2K |
|
|
HYPD
3318
Hyperion DeFi Inc
HYPD
$40.3M
| $89.5K | ﹤0.01% |
+317
| New | +$67.1K |
|
3319
CorMedix
CRMD
$588M
| $89.4K | ﹤0.01% |
21,601
| – | – |
|
3320
Kartoon Studios
TOON
$35.1M
| $89.3K | ﹤0.01% |
+32,707
| New | +$149K |
|
|
ICAD
3321
DELISTED
iCAD Inc
ICAD
| $88.1K | ﹤0.01% |
70,988
| – | – |
|
3322
Medallion Financial
MFIN
$233M
| $87.8K | ﹤0.01% |
11,451
| – | – |
|
|
SPRB
3323
Spruce Biosciences
SPRB
$119M
| $86.6K | ﹤0.01% |
522
+385
| +281% | +$71.5K |
|
3324
PharmaCyte Biotech
PMCB
$6.44M
| $85.3K | ﹤0.01% |
+29,303
| New | +$86.1K |
|
|
ORKA
3325
Oruka Therapeutics
ORKA
$5.9B
| $84.6K | ﹤0.01% |
3,542
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Dimensional Fund Advisors held 3,570 positions worth $297B, up 87,611% from $338M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q1 2023 filing shows 79 new, 2,112 increased, 1,113 reduced and 109 closed positions. Its largest new stake was GE HealthCare: 1,253,762 shares worth $103M. The largest sale was Walmart Inc, an estimated $320M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2023 buy was GE HealthCare: 1,253,762 shares worth $103M.
- Dimensional Fund Advisors added most to Apple in Q1 2023, an estimated $150M increase.
- Dimensional Fund Advisors's biggest Q1 2023 reduction was Walmart Inc, cutting an estimated $320M.
- Dimensional Fund Advisors fully exited Dimensional Emerging Markets Sustainability Core 1 ETF in Q1 2023, selling an estimated $11.3M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $297B portfolio in Q1 2023.
- Dimensional Fund Advisors opened 79 new positions and closed 109 in Q1 2023.
- Dimensional Fund Advisors's portfolio value rose 87,611% quarter-over-quarter to $297B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.